{"organizations": [], "uuid": "aead7f8c2f34df33a4daf01bbf42d2151b739029", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://feeds.reuters.com/reuters/companyNews", "section_title": "Reuters: Company News", "url": "https://www.reuters.com/article/brief-aviragen-therapeutics-comments-on/brief-aviragen-therapeutics-comments-on-iss-report-idUSFWN1PL18X", "country": "US", "domain_rank": 408, "title": "BRIEF-Aviragen Therapeutics Comments on ISS Report", "performance_score": 0, "site": "reuters.com", "participants_count": 0, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-01-26T23:51:00.000+02:00", "replies_count": 0, "uuid": "aead7f8c2f34df33a4daf01bbf42d2151b739029"}, "author": "", "url": "https://www.reuters.com/article/brief-aviragen-therapeutics-comments-on/brief-aviragen-therapeutics-comments-on-iss-report-idUSFWN1PL18X", "ord_in_thread": 0, "title": "BRIEF-Aviragen Therapeutics Comments on ISS Report", "locations": [], "entities": {"persons": [], "locations": [], "organizations": []}, "highlightText": "", "language": "english", "persons": [], "text": " 52 PM / in 17 minutes BRIEF-Aviragen Therapeutics Comments on ISS Report Reuters Staff 1 Min Read \nJan 26 (Reuters) - Aviragen Therapeutics Inc: \n* AVIRAGEN THERAPEUTICS - ISSUED STATEMENT IN RESPONSE TO REPORT BY INSTITUTIONAL SHAREHOLDER SERVICES REGARDING COâ€˜S PROPOSED MERGER WITH VAXART INC \n* AVIRAGEN THERAPEUTICS INC - AVIRAGEN BOARD OF DIRECTORS UNANIMOUSLY RECOMMENDS THAT STOCKHOLDERS VOTE FOR PROPOSED MERGER WITH VAXART Source text for Eikon: Further company coverage:", "external_links": [], "published": "2018-01-26T23:51:00.000+02:00", "crawled": "2018-01-27T00:04:07.020+02:00", "highlightTitle": ""}